Drawing for F-BALM

USPTO serial 87672106

F-BALM

Reviewed by CopyMark Law Group

Reg. 5997510Status 702Registered
Filing date
Status date
Registration date
Feb 25, 2020
Examiner
LAMONT, JOHN CHRISTOPHER
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with F-BALM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Beauty masks; Facial masks; Skin masks; Non-medicated skin care preparationsACTIVEJan 1, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 18, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 18, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 17, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 25, 2025E815TEAS SECTION 8 & 15 RECEIVED
Feb 25, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 11, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 11, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 11, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 11, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 11, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 3, 2021ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 3, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 25, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 24, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 23, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 16, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jan 16, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 3, 2020IUAFUSE AMENDMENT FILED
Jan 3, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Oct 8, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2019EX3GSOU EXTENSION 3 GRANTED
Oct 4, 2019EXT3SOU EXTENSION 3 FILED
Oct 4, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 28, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2019EX2GSOU EXTENSION 2 GRANTED
Mar 15, 2019EXT2SOU EXTENSION 2 FILED
Mar 15, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 10, 2018EX1GSOU EXTENSION 1 GRANTED
Oct 10, 2018EXT1SOU EXTENSION 1 FILED
Oct 10, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 26, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 24, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 27, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 27, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 7, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jan 10, 2018DOCKASSIGNED TO EXAMINER
Nov 14, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance